Last week GlaxoSmithKline (GSK), one of the world’s leading research-based pharmaceutical and healthcare companies and the PATH Malaria Vaccine Intiative (MVI), announced that the world may be closer to a malaria vaccine than once thought.  Working together, MVI and GSK announced results from a large scale trail in Africa testing the RTS,S vaccine which demonstrated…

Read More

John Donnelly interviews Dr. Roma Chilengi, head of clinical trials at the KEMRI-Wellcome Trust Research Programme in Kenya. Dr. Roma Chilengi was the head of clinical trials at the Kenya Medical Research Institute(KEMRI)-Wellcome Trust Research Programme in Kilifi, Kenya, from 2008 until April 2011. While he worked on several vaccine trials, Chilengi specialized in malaria vaccine…

Read More

VIENNA, Austria – The nature of scientific research is iterative and incremental – adding to the evidence base, moving a step forward here and there. But not all steps are created equal and every so often the next step is downright exciting. HIV/AIDS has had a few of those exciting steps: identifying the virus that…

Read More